This report provides a detailed analysis of GlaxoSmithKline's (GSK) marketing plan, focusing on a new flu vaccine. The report begins with an introduction to marketing plans and a summary of GSK's operations, particularly its focus on pharmaceuticals, vaccines, and healthcare products. Task 1 covers the review of new products, sales strategies, marketing concepts, and competitor benchmarking, including an analysis of GSK's strengths, weaknesses, opportunities, and threats (SWOT). Task 2 examines various marketing barriers, such as environmental, cultural, and behavioral barriers, and proposes methods to overcome them, including organizational structure improvements, setting targets, and reducing perception differences. Task 3 includes the marketing plan, external analysis, marketing objectives, market segmentation (demographic), targeting strategy (elderly), and positioning. The report also discusses the significance of the marketing plan in strategic planning and justifies the selected strategies, such as product development and cost leadership, with retail market distribution. The report concludes with a summary of findings and references.